Form 8-K GoodRx Holdings, Inc. For: Feb 28

Go back to Form 8-K GoodRx Holdings, Inc. For: Feb 28

GoodRx Holdings Inc. (GDRX) PT Lowered to $30 at Goldman Sachs

March 1, 2022 6:58 AM EST

Goldman Sachs analyst Eric Sheridan lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $30.00 (from $43.00) while maintaining a Buy rating following results.

The analyst commented, "We reiterate our Buy rating but lower our PT from $43 to $30 to reflect both lowered operating... More

GoodRx Holdings Inc. (GDRX) PT Lowered to $20 at JPMorgan

March 1, 2022 4:58 AM EST

JPMorgan analyst Doug Anmuth lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $20.00 (from $33.00) while maintaining a Underweight rating.

The analyst comments "GoodRx is focused on building the top consumer-focused digital healthcare platform in the US. Its core offering tracks... More